SNVs · Indels · CNVs
Identify single-nucleotide variants, insertions/deletions and copy-number variants in a single workflow.
A clinical-grade platform that operates natively on ISO/IEC 23092 (MPEG‑G) conformant sequencing data — enabling accurate variant identification, annotation and interpretation to support diagnostic and treatment decisions.
Targeted at hereditary-disease diagnostics through whole-exome sequencing, GVD delivers a fully integrated secondary and tertiary analysis — directly in MPEG‑G — combining cutting-edge bioinformatics with an intuitive interface designed for clinical geneticists.
Identify single-nucleotide variants, insertions/deletions and copy-number variants in a single workflow.
Integrated with a continuously curated human genetic-variants database — annotation that keeps up with the literature. The database can be integrated with the source of your choice on request.
A large set of easy-to-use yet powerful features for narrowing down candidate variants by frequency, classification, zygosity, gene panel and more.
Focus on the genetic targets you care about without re-processing the whole dataset — possible because of MPEG‑G.
Patient data stays protected end-to-end thanks to MPEG‑G's built-in encryption and signature primitives.
Run on a managed cloud environment or deploy on your own servers — same workflow, same results.
Variant-calling pipelines built to comply with GATK best practices — for results that are reproducible and clinically trusted.
The GenomSys Variant Discovery is CE-marked as an in-Vitro Diagnostic Medical Device under directive 98/79/CE — approved for clinical-grade diagnostic purposes. The platform is developed and maintained under our ISO 13485 quality-management system.
MPEG‑G native — sequencing data arrives smaller, transmits faster and is ready for analysis with no intermediate conversion.
Built for clinical geneticists, not engineers. Sign in, drop your file, and start interpreting.
Variant annotation evolves continuously — and so does GVD's curated database integration.
Designed around the daily reality of clinical geneticists and laboratory professionals — and the workflows of sequencing and genomic research centers running hereditary-disease diagnostics at scale.
Reviewing variants for diagnostic and treatment-selection decisions.
Running WES-based hereditary-disease panels in production.
Delivering downstream analysis as part of a broader genomic service.
Translating variant discoveries into clinical research workflows.